EnCore Energy Corp. (NYSE American: EU | TSXV: EU) has announced the successful startup of uranium production from its Rosita ISR Uranium Central Processing Plant (Rosita CPP) in southern Texas, USA. The restart of the previously producing plant is the first step in enCore’s south Texas production pipeline strategy utilizing the in-situ recovery production process.
Wellfield production patterns are operating, oxygenated water is circulating through the satellite ion exchange (IX) facility and being injected back into the uranium ore body. The company looks forward to continuing increases in uranium concentration into the satellite IX facility over the coming weeks and is anticipating its first shipment of uranium to occur over the next 45 to 60 days.
“It is with great satisfaction that in less than 20 months’ time, the enCore team completed the refurbishment and upgrading of the Rosita CPP from long-term cold standby to monitor well ring installation, wellfield pattern and infrastructure installation, and construction of a new satellite IX facility,” commented EnCore CEO Paul Goranson.
“Our team has aggressively worked through supply chain disruptions and a significant expansion of our operating workforce to meet our targeted production schedule. We are very pleased to have our first uranium production underway at enCore, and…to be both the first uranium producer in Texas in 10 years and the newest uranium producer in the US.”
The wholly-owned Rosita CPP, located approximately 60mi from Corpus Christi, is a licensed, past-producing in-situ recovery (ISR) uranium plant with a capacity of 800Klbspa and the ability to expand capacity within the existing licence.
Located in the Texas uranium belt, the Rosita CPP and Wellfield lie within over 2,700 acres of mineral rights. The plant is designed to process uranium feed from multiple satellite operations, all located in the south Texas area and is one of eleven licenced uranium processing plants in the US, three of which are owned by enCore Energy Corp.
For further information, please visit: www.encoreuranium.com
To read more articles like this, please visit: www.theassay.com